NCT00275236已完成3 期
A Multi-center, Double-blind, Randomized, Placebo-controlled, Two-arm, Parallel-group, Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- UCB Pharma
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- Efficacy is assessed by reduction of Periodic Limb Movement Index, which will be obtained from polysomnographic measurements.
研究概览
简要总结
The objective of this trial is to demonstrate that rotigotine (SPM 936) is effective in subjects with idiopathic RLS based on the PLMI (Periodic Limb Movements Index)(PLMs/total time in bed) as measured by polysomnography (PSG). The primary variable is the reduction of PLMI at the end of the Maintenance Period compared to Baseline. PLMI data will be obtained from PSGs.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 75 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Idiopathic RLS
排除标准
- •secondary RLS
- •history of sleep disturbances
- •symptomatic orthostatic hypotension
结局指标
主要结局
Efficacy is assessed by reduction of Periodic Limb Movement Index, which will be obtained from polysomnographic measurements.
次要结局
- Changes in Periodic Limb Movement Arousal Index, Sleep efficiency, International RLS sum score, Clinical Global Impression Item 1.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg SyndromeRestless Legs SyndromeNCT00136045UCB Pharma549
终止
3 期
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal DysfunctionAdvanced Parkinson's DiseaseNCT01536015UCB Pharma25
已完成
4 期
Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor SymptomsIdiopathic Parkinson's DiseaseNCT01300819UCB Pharma349
已完成
2 期
Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS SymptomsRestless Legs SyndromeNCT00389831UCB Pharma44
已完成
3 期
Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal PatchParkinson's DiseaseNCT00522379UCB Pharma514
